Hikma Pharmaceuticals PLC

HKMPY · OTC
Analyze with AI
Key StatsIncome StatementBalance SheetCash Flow
AnnualQuarterly
KMB
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets––––
Cash & Equivalents$188$205$270$426
Short-Term Investments$25$24$22$24
Receivables$905$789$777$784
Inventory$986$891$776$695
Other Curr. Assets$159$191$154$165
Total Curr. Assets$2,263$2,100$1,999$2,094
Property Plant & Equip (Net)$1,326$1,141$1,081$1,146
Goodwill$382$388$389$285
Intangibles$774$712$735$607
Long-Term Investments$51$75$53$33
Tax Assets$293$226$192$183
Other NC Assets$44$38$22$24
Total NC Assets$2,870$2,580$2,472$2,278
Other Assets$0$0$0$0
Total Assets$5,133$4,680$4,471$4,372
Liabilities––––
Payables$358$309$291$262
Short-Term Debt$653$161$148$121
Tax Payable$78$74$73$57
Deferred Revenue$0$0$193$294
Other Curr. Liab.$889$795$372$282
Total Curr. Liab.$1,978$1,339$1,077$1,016
LT Debt$653$1,030$1,135$725
Deferred Rev, NC$30$0$0$0
Deferred Tax Liab, NC$18$25$19$24
Other NC Liab.$133$77$92$140
Total NC Liab.$834$1,132$1,246$889
Other Liabilities$0$0$0$0
Cap. Leases$57$66$70$83
Total Liabilities$2,812$2,471$2,323$1,905
Equity––––
Pref Stock$0$0$0$0
Common Stock$40$40$40$42
Retained Earnings$2,362$2,158$2,092$2,189
AOCI-$337-$282-$279-$60
Other Equity$245$282$282$282
Total Equity$2,310$2,198$2,135$2,453
Supplemental Information––––
Minority Interest$11$11$13$14
Total Liab. & Tot. Equity$5,133$4,680$4,471$4,372
Net Debt$1,118$986$1,013$420